This invention relates to novel phenyl amide or pyridyl amide derivatives of the formula
wherein A1, A2, B1, B2 and R1 to R11 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.
NOVEL PHENYL AMIDE OR PYRIDIL AMIDE DERIVATIVES AND THEIR USE AS GPBAR1 AGONISTS
申请人:F. Hoffmann-La Roche AG
公开号:EP2356094A1
公开(公告)日:2011-08-17
US8309734B2
申请人:——
公开号:US8309734B2
公开(公告)日:2012-11-13
[EN] NOVEL PHENYL AMIDE OR PYRIDIL AMIDE DERIVATIVES AND THEIR USE AS GPBAR1 AGONISTS<br/>[FR] NOUVEAUX DÉRIVÉS D'AMIDES PHÉNYLIQUES OU D'AMIDES PYRIDYLIQUES ET LEUR UTILISATION EN TANT AGONISTES DE GPBAR1
申请人:HOFFMANN LA ROCHE
公开号:WO2010049302A1
公开(公告)日:2010-05-06
This invention relates to novel phenyl amide or pyridyl amide derivatives of the formula (I) wherein A1, A2, B1, B2 and R1 to R11 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.
NOVEL PHENYL AMIDE OR PYRIDYL AMIDE DERIVATIVES
申请人:Bissantz Caterina
公开号:US20100105906A1
公开(公告)日:2010-04-29
This invention relates to novel phenyl amide or pyridyl amide derivatives of the formula
wherein A
1
, A
2
, B
1
, B
2
and R
1
to R
11
are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.